Shih-Ping Liu

Title: Innovations of Inventor Shih-Ping Liu

Introduction

Shih-Ping Liu is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of stem cell research and adipose cell differentiation. With a total of 2 patents, his work focuses on innovative applications that have the potential to impact medical treatments and therapies.

Latest Patents

Liu's latest patents include "Applications of butylidenephthalide" and "Induced pluripotent stem cells (iPSCs) and applications thereof." The first patent discusses the use of butylidenephthalide (BP) in creating a kit that promotes the differentiation of stem cells into brown adipose cells. It also details the use of BP in preparing a medicament aimed at inhibiting the accumulation of white adipose cells, promoting their conversion into brown adipose cells, and reducing weight gain and blood levels of triglycerides, glucose, and total cholesterol. The second patent provides methods for generating iPSCs from somatic cells that include a Cbx family gene, ensuring that these cells do not possess oncogenic properties. This innovation opens avenues for transplantation and cellular differentiation.

Career Highlights

Shih-Ping Liu has worked at prestigious institutions such as National Dong Hwa University and China Medical University. His research has been pivotal in advancing the understanding of stem cell applications and their therapeutic potential.

Collaborations

Liu has collaborated with notable colleagues, including Tzyy-Wen Chiou and Shinn-Zong Lin. These partnerships have contributed to the development of his innovative research and patents.

Conclusion

Shih-Ping Liu's contributions to the field of stem cell research and adipose cell differentiation highlight his role as a leading inventor. His patents reflect a commitment to advancing medical science and improving health outcomes.